Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats
- 1 July 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Menopause
- Vol. 13 (4), 669-677
- https://doi.org/10.1097/01.gme.0000196596.90076.d0
Abstract
Objective: The flavonoid 8-prenylnaringenin (8-PN) is found in hops, and hence in beer, and is also increasingly consumed as a food supplement. It is the strongest known phytoestrogen, which makes it a good candidate as an alternative to hormone therapy. Its putatively undesired estrogenic effects in the uterus and mammary gland have not yet been thoroughly investigated. Therefore, we performed a long-term oral administration experiment. Design: Rats were ovariectomized and fed for 3 months with soy-free chow containing estradiol (E2) or 8-PN, both in two doses (8-PN: 6.77 mg or 68.42 mg/kg body weight; E2: 0.17 mg or 0.7 mg/kg body weight) or no additives. Analysis was mainly focused on morphologic and immunocytochemical parameters. Expression of proliferating cell nuclear antigen as a proliferation marker and of progesterone receptor was quantified in the mammary gland. Results: Uteri of animals treated with both E2 doses and the high 8-PN dose had increased weight and showed histologic estrogen-induced features. 8-PN at the high dose induced epithelial polypoid formation unique to this group. Compared to the atrophic controls, both E2 doses and the high 8-PN dose induced hyperplastic epithelia in the vagina. The high doses of E2 and 8-PN caused secretion in the mammary gland, whereas proliferation and progesterone receptor expression were stimulated by both E2 doses and the high 8-PN dose. Conclusions: E2 and 8-PN share many effects in the three studied organs, but some differences in the mechanism of action appear to exist.Keywords
This publication has 24 references indexed in Scilit:
- Rapid yeast estrogen bioassays stably expressing human estrogen receptors α and β, and green fluorescent protein: a comparison of different compounds with both receptor typesThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Questions About Hormone Therapy Remain PuzzlingPublished by American Medical Association (AMA) ,2002
- Postmenopausal Hormone Replacement TherapyJAMA, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Estrogenic Activity of the Phytoestrogens Naringenin, 6-(1,1-Dimethylallyl)naringenin and 8-PrenylnaringeninPlanta Medica, 2002
- Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancementFood and Chemical Toxicology, 2001
- Determination of the Hop-Derived Phytoestrogen, 8-Prenylnaringenin, in Beer by Gas Chromatography/Mass SpectrometryJournal of Agricultural and Food Chemistry, 1999
- Identification of a Potent Phytoestrogen in Hops (Humulus lupulus L.) and BeerJournal of Clinical Endocrinology & Metabolism, 1999
- Postmenopausal Hormone-Replacement Therapy — Time for a Reappraisal?New England Journal of Medicine, 1997
- Reduced Mortality Associated With Long-Term Postmenopausal Estrogen TherapyPublished by Ovid Technologies (Wolters Kluwer Health) ,1996